CASPOFUNGINE STRAGEN 70 mg, powder for concentrate for infusion bottle
Active ingredients: Caspofungin acetate, Caspofungin
Commercialized according to BDPMDispensing in France: Prescription only
Powder for concentrate for infusionbottleintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CASPOFUNGINE STRAGEN 70 mg, poudre pour solution à diluer pour perfusion
- Pharmaceutical form
- poudre pour solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 70 mg
- Marketing authorisation holder
- STRAGEN-FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Sept 2017
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63197689CIP73008443CIP133400930084434Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CASPOFUNGINE BASEpoudre | 70 mg · un flacon | FT |
| CASPOFUNGINE (ACÉTATE DE)poudre | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.